AS03

Source: Wikipedia, the free encyclopedia.

AS03 (for "Adjuvant System 03") is the trade name for a

pandemic flu vaccine Pandemrix. It is also in Arepanrix and the Q-pan for H5N1 influenza.[1] A dose of AS03 adjuvant contains[2]

In the

H1N1 influenza than non-adjuvanted vaccines, despite their containing lower levels of viral antigen.[3]

Small observational studies reported from Finland and Sweden in 2012, and larger studies from Ireland reported in 2012, and reported in each of England, Norway and France in 2013, found an association between narcolepsy and an A(H1N1)pdm09 vaccine that used AS03 adjuvant; the rates ranged from one in 16,000 doses to one in 50,000 doses.[4] As of 2016 it was unclear whether or not the adjuvant was responsible; other suspected causes include genetic susceptibility, exposure to A(H1N1)pdm09, manufacturing impurities, or combinations of these factors.[4]

See also

  • 2009 flu pandemic
  • MF59 – another squalene-based adjuvant by Novartis
  • AS04 – another adjuvant by GSK

References

  1. ^ "FDA panel endorses H5N1 vaccine with adjuvant". 15 Nov 2012.
  2. ^ Pandemrix – Summary of product characteristics Archived October 7, 2009, at the Wayback Machine, European Medicines Agency websiteEuropean Medicines Agency website Archived 2013-07-15 at the Wayback Machine
  3. PMID 21668694
    .
  4. ^ .


This page is based on the copyrighted Wikipedia article: AS03. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy